T1	Participants 45 74	head and neck cancer surgery:
T2	Participants 187 222	patients with head and neck cancer.
T3	Participants 626 720	A population of 44 patients with oral and laryngeal cancer was enrolled in a randomized trial.
T4	Participants 1808 1838	head and neck cancer patients.
